Adult Patient Simulators Segment to Register Highest CAGR in Patient Simulators Market During 2022-2028

According to our latest study on "Patient Simulators Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Product and End User," the market is projected to reach US$ 4,284.03 million by 2028 from US$ 1,599.41 million in 2021; it is expected to register a CAGR of 15.2% from 2022 to 2028. The report highlights the key factors driving the market and prominent players with their developments in the patient simulators market.

The COVID-19 pandemic positively impacted the global patient simulators market. The research and development for studying COVID-19 with the help of manikin have fueled the demand for patient simulators. Simulators also played a significant role in preparing medical professionals to treat COVID-19 patients. At the onset of the pandemic, the rapid escalation in cases caught many facilities and staff unprepared. Because healthcare professionals working in critical care have vastly different skillsets from those in the emergency department or the medical surgery floor, many did not have the skills to treat patients with COVID-19 properly. This resulted in increased demand for simulators and skills trainers, not only to train new providers but also to cross-train healthcare professionals from other departments who were helping to meet the demands of COVID-19. Due to the pandemic, there has been an increased reliance on robot-like patient simulators for training.

Based on product, the patient simulators market is segmented into adult patient simulator, infant simulator, and childbirth simulator. In 2021, the adult patient simulator segment held the largest market share. Also, the same segment is anticipated to register the highest CAGR during the forecast period. Based on end user, the patient simulators market is segmented into academic institutes, hospitals, and military organizations. In 2021, the academic institutes segment accounted for the largest market share. Also, the same segment is expected to register the highest CAGR from 2022 to 2028.

A patient simulator is a manikin used to train healthcare professionals and students to study human anatomy or function (physiology). Patient simulators can also be combined with computer software, replicating normal and abnormal bodily reactions to events, such as asthma attacks, and therapeutic interventions, including drug side effects. Simulated blood can be pumped into the veins through an intravenous (IV) tube. Patient simulators are life-like manikins that react physiologically like a normal human being. The simulators are specifically designed, keeping respiratory therapy, nursing, and emergency medical students in mind. Additionally, simulation is the only teaching method that provides repeated hands-on experience with real-time feedback in a safe, controlled environment without causing any harm or inconvenience to real patients. The need for simulator training for in-service education of existing healthcare professionals is growing rapidly and has been amplified by the COVID-19 pandemic. A study published by the National Council of State Boards of Nursing (NCSBN) found that training with the simulator is as effective as clinical training with a patient in training nursing students. NCSBN authorized that up to 50% of the students' clinical time could be done via a simulator in an optimally designed simulation training program. Thus, the growing use of simulators in teaching hospitals, nursing schools, military medical training, and paramedic training centers for training purposes is driving the patient simulators market.

CAE Inc, Laerdal Medical AS, Gaumard Scientific Co Inc, Kyoto Kagaku Co Ltd, Surgical Science Sweden AB, Simulab Corp, Simulaids Ltd, Mentice AB, Limbs & Things Ltd, and VirtaMed AG are among the leading companies operating in the patient simulators market.

In terms of geography, the patient simulators market has been segmented as follows:

Based on geography, the patient simulators market is primarily segmented into North America, Europe, Asia Pacific (APAC), the Middle East & Africa (MEA), and South & Central America. The patient simulators market in North America is further segmented into the US, Canada, and Mexico. The European patient simulators market is subsegmented into France, Germany, the UK, Spain, Italy, and the Rest of Europe. The patient simulators market in APAC is segmented into Japan, China, India, Australia, South Korea, and the Rest of APAC. The patient simulators market in the MEA is further segmented into Saudi Arabia, the UAE, South Africa, and the Rest of the MEA. The patient simulators market in South & Central America is further segmented into Brazil, Argentina, and the Rest of South & Central America.

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com